Peri-op Chemo Found Beneficial for Resected Lung Cancers

Share this content:

(ChemotherapyAdvisor) – Perioperative chemotherapy may be beneficial in patients with resected small-cell lung cancer (SCLC) or large-cell neuroendocrine carcinoma (LCNEC), according to a team of researchers of Surgical Centre Marie Lannelongue, Le Plessis Robinson, France. This conclusion is based on study entitled “Effect of Chemotherapy in Patients with Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma,” which is published in the July issue of the Journal of Thoracic Oncology.

“The benefit of perioperative chemotherapy in resected SCLC or LCNEC is not clear,” the investigators wrote. The benefits were evaluated in this retrospective analysis of perioperative treatments with survival follow up.

The investigators reported that among 74 patients with tumor resection, 45 had received chemotherapy. Eleven patients were women. Four patients in the surgery-alone group and 11 in the surgery-plus-chemotherapy group had LCNEC. “There were 10 node positive tumors and only two incomplete resections in the surgery group vs. 27 node positive tumors and 3 incomplete resections in the surgery-plus-chemotherapy group,” the investigators wrote. Among the patients with a survival or a follow-up of at least six months, median survival was 2.3 and 6.1 years in the surgery (n=20) and surgery plus chemotherapy (n=39) groups, respectively, such that the hazard ratio for death was 0.48 (95% confidence interval, 0.24–0.99, P=0.04).

The investigators concluded that perioperative chemotherapy may be beneficial in patients with resected SCLC or LCNEC.

Abstract

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs